RiverFront Investment Group’s ResMed RMD Stock Holding History

RiverFront Investment Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-752	Closed	-$206K	–	356
2025 Q3	$206K	Buy	+752	New	+$205K	﹤0.01%	310

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

RiverFront Investment Group's RMD Position: Q4 2025 in Review

RiverFront Investment Group sold out of ResMed (RMD) in Q4 2025, closing a stake of 752 shares — an estimated $206K sold.

RiverFront Investment Group first reported a position in RMD in Q3 2025 and held it in 1 quarter. The position peaked at $206K in Q3 2025. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

RiverFront Investment Group reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
RiverFront Investment Group sold 752 ResMed shares in Q4 2025, an estimated $206K.
RiverFront Investment Group first reported a position in ResMed in Q3 2025 and held it in 1 quarter.
RiverFront Investment Group's ResMed position peaked at $206K in Q3 2025.
947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on RiverFront Investment Group's 13F filing for Q4 2025, filed 5 Feb 2026.